Market Overview

Teva Announces Signing of New $3B Syndicated Revolving Credit Line

Share:
Related TEVA
Nothing Generic About This ETF's Long-Term Outlook
Allergan Again A Core Holding At UBS

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

Posted-In: News Financing

 

Related Articles (TEVA)

View Comments and Join the Discussion!